REG - Hikma Pharmaceutical - Director/PDMR Shareholding
RNS Number : 5260NHikma Pharmaceuticals Plc20 May 2020
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 20 May 2020: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 16 May 2018 under the 2014 Executive Incentive Plan ("EIP") Element B which was completed on 19 May 2020.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Mazen Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mazen Darwazah
2
Reason for the notification
a)
Position/status
Executive Vice Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from vesting of the conditional awards on
18 May 2020 under the 2014 EIP Element B.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 16,953
d)
Aggregated information
N/A
e)
Date of the transaction
19 May 2020
f)
Place of the transaction
London Stock Exchange (XLON)
Riad Mishlawi
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Riad Mishlawi
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from vesting of the conditional awards on
18 May 2020 under the 2014 EIP Element B.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 22,601
d)
Aggregated information
N/A
e)
Date of the transaction
19 May 2020
f)
Place of the transaction
London Stock Exchange (XLON)
Majda Labadi
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Majda Labadi
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from vesting of the conditional awards on
18 May 2020 under the 2014 EIP Element B.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 15,855
d)
Aggregated information
N/A
e)
Date of the transaction
19 May 2020
f)
Place of the transaction
London Stock Exchange (XLON)
Bassam Kanaan
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Bassam Kanaan
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from vesting of the conditional awards on
18 May 2020 under the 2014 EIP Element B.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 25,729
d)
Aggregated information
N/A
e)
Date of the transaction
19 May 2020
f)
Place of the transaction
London Stock Exchange (XLON)
Khalid Nabilsi
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Khalid Nabilsi
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from vesting of the conditional awards on
18 May 2020 under the 2014 EIP Element B.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 23,062
d)
Aggregated information
N/A
e)
Date of the transaction
19 May 2020
f)
Place of the transaction
London Stock Exchange (XLON)
Brian Hoffmann
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Brian Hoffmann
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Shares acquired from vesting of the conditional awards on
18 May 2020 under the 2014 EIP Element B.c)
Price(s) and volume(s)
Price(s): £nil
Volume(s): 18,247
d)
Aggregated information
N/A
e)
Date of the transaction
19 May 2020
f)
Place of the transaction
London Stock Exchange (XLON)
Hussein Arkhagha
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Hussein Arkhagha
2
Reason for the notification
a)
Position/status
PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083
b)
Nature of the transaction
Disposal of Shares acquired from vesting of the conditional awards on 18 May 2020 under the 2014 EIP Element B.
c)
Price(s) and volume(s)
Price(s): £24.629
Volume(s): 13,489
d)
Aggregated information
Aggregated volume: 13,489
Price: £332,220.58
e)
Date of the transaction
19 May 2020
f)
Place of the transaction
London Stock Exchange (XLON)
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHBSGDUGSDDGGG
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma appoints new President of Generics business
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement